Cargando…
HMGB1 as a potential biomarker and therapeutic target for severe COVID-19
COVID-19 has attracted global attention due to its rapid spread around the world with substantial morbidity and associated mortality. Severe COVID-19 can be complicated by the acute respiratory distress syndrome, sepsis and septic shock leading to death. These complications are thought to result fro...
Autores principales: | Chen, Ruochan, Huang, Yan, Quan, Jun, Liu, Jiao, Wang, Haichao, Billiar, Timothy R., Lotze, Michael T., Zeh, Herbert J., Kang, Rui, Tang, Daolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720697/ https://www.ncbi.nlm.nih.gov/pubmed/33313438 http://dx.doi.org/10.1016/j.heliyon.2020.e05672 |
Ejemplares similares
-
Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer
por: Kang, Rui, et al.
Publicado: (2017) -
The mechanism of HMGB1 secretion and release
por: Chen, Ruochan, et al.
Publicado: (2022) -
cAMP metabolism controls caspase-11 inflammasome activation and pyroptosis in sepsis
por: Chen, Ruochan, et al.
Publicado: (2019) -
PKM2 Regulates the Warburg Effect and Promotes HMGB1 Release in Sepsis
por: Yang, Liangchun, et al.
Publicado: (2014) -
Novel chemokine-like activities of histones in tumor metastasis
por: Chen, Ruochan, et al.
Publicado: (2016)